ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 277 filers reported holding ROYALTY PHARMA PLC in Q1 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $155,458 | -7.8% | 5,728 | +4.4% | 0.00% | 0.0% |
| Q2 2023 | $168,640 | -15.0% | 5,486 | -0.4% | 0.00% | 0.0% |
| Q1 2023 | $198,489 | -8.0% | 5,509 | +1.0% | 0.00% | 0.0% |
| Q4 2022 | $215,661 | -1.5% | 5,457 | -0.2% | 0.00% | 0.0% |
| Q3 2022 | $219,000 | -4.4% | 5,469 | +0.2% | 0.00% | 0.0% |
| Q2 2022 | $229,000 | +7.5% | 5,457 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $213,000 | +43.0% | 5,457 | +45.5% | 0.00% | 0.0% |
| Q4 2021 | $149,000 | +1390.0% | 3,750 | +1394.0% | 0.00% | – |
| Q2 2021 | $10,000 | -90.0% | 251 | -87.4% | 0.00% | – |
| Q4 2020 | $100,000 | +19.0% | 2,000 | 0.0% | 0.00% | – |
| Q3 2020 | $84,000 | -13.4% | 2,000 | 0.0% | 0.00% | -100.0% |
| Q2 2020 | $97,000 | – | 2,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Siguler Guff Advisers, LLC | 3,391,754 | $122,204,897 | 47.65% |
| Vantage Consulting Group Inc | 1,022,194 | $36,829,650 | 20.91% |
| Indie Asset Partners, LLC | 433,000 | $15,600,990 | 18.22% |
| Overbrook Management Corp | 578,783 | $20,853,551 | 5.46% |
| Silicon Valley Community Foundation | 1,032,320 | $37,194,490 | 5.36% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,047,049 | $109,785,175 | 4.64% |
| Geo Capital Gestora de Recursos Ltd | 142,748 | $5,143 | 3.81% |
| Renaissance Capital LLC | 123,913 | $4,464,585 | 3.31% |
| Rokos Capital Management LLP | 1,106,813 | $40,077,698 | 2.96% |
| Lagoda Investment Management, L.P. | 101,500 | $3,657,045 | 2.60% |